COLLABORATING FOR PATIENT IMPACT
What Is Precision Medicine?
Precision medicine seeks to more accurately inform diagnosis, and also help health care providers identify potential treatments for patients.1 Testing for certain biologic or genomic characteristics, also known as biomarkers, can assist health care providers in determining an appropriate option for the right patient throughout their treatment process.2,3
Resources
Explore informative educational resources.
Masterclass Video
Pre-Testing: Working Together Toward Testing
Biomarker Testing in Select GI Cancers
NCCN Recommendations for Biomarker Testing in Select GI Cancers
Communicating Results in the Pathology Report
MSI/MMR Testing Results in the Pathology Report
CPS Scoring Video
Utilizing CPS to Evaluate PD-L1 Expression Video
SDoH Overview
GI = gastrointestinal; NCCN = National Comprehensive Cancer Network; PML = precision medicine liaison; CPS = combined positive score; PD-L1 = programmed death ligand 1; SDoH = Social Determinants of Health.
References. 1. Nassar SF et al. Cells. 2020;9:2056. 2. Schwartzberg L et al. Am Soc Clin Oncol Educ Book. 2017;37:160–169. 3. Puranik AD et al. Cancer J. 2015;21:213–217.